Evidence map›Paper›PMID 38630620›Full record

ReviewCardiovascular research2024

Mast cells: a novel therapeutic avenue for cardiovascular diseases?

Remo Poto, Gianni Marone, Stephen J Galli, Gilda Varricchi

Open access · bronzeAbstract readReview
In one paragraph

Review in Cardiovascular research, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Vascular remodeling in asthma: from mechanisms to precision medicine.Current opinion in allergy and clinical immunology · 2026
    Review
  5. Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 2 countries.

Remo PotoDepartment of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini 5, Naples 80131, Italy.ORCID 0000-0002-4723-0167
Gianni MaroneDepartment of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini 5, Naples 80131, Italy.ORCID 0000-0002-9849-4701
Stephen J GalliDepartment of Pathology and the Sean N. Parker Center for Allergy and Asthma Research, Stanford University School of Medicine, 291 Campus Dr, Stanford, CA, USA.ORCID 0000-0001-5736-5340
Gilda VarricchiDepartment of Translational Medical Sciences, University of Naples Federico II, Via S. Pansini 5, Naples 80131, Italy.ORCID 0000-0002-9285-4657
Institute for Experimental Endocrinology and Oncology · ITStanford University · USWorld Health Organization - Italy · IT

Funding

Tracking allergen specific T cells in multi-food allergyU19AI104209 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2013 to 2025
$17.3M
Characterization of degranulation regulators in human mast cellsR21AI163438 · NIAID · STANFORD UNIVERSITY · PI GALLI, STEPHEN JOSEPH · 2021 to 2022
$433k
Campania Bioscience ProjectNIAID NIH HHS R21 AI163438NIAID NIH HHS U19 AI104209TIMINGUniversity of Naples Federico II
6 · The paper itself

Abstract

Mast cells are tissue-resident immune cells strategically located in different compartments of the normal human heart (the myocardium, pericardium, aortic valve, and close to nerves) as well as in atherosclerotic plaques. Cardiac mast cells produce a broad spectrum of vasoactive and proinflammatory mediators, which have potential roles in inflammation, angiogenesis, lymphangiogenesis, tissue remodelling, and fibrosis. Mast cells release preformed mediators (e.g. histamine, tryptase, and chymase) and de novo synthesized mediators (e.g. cysteinyl leukotriene C4 and prostaglandin D2), as well as cytokines and chemokines, which can activate different resident immune cells (e.g. macrophages) and structural cells (e.g. fibroblasts and endothelial cells) in the human heart and aorta. The transcriptional profiles of various mast cell populations highlight their potential heterogeneity and distinct gene and proteome expression. Mast cell plasticity and heterogeneity enable these cells the potential for performing different, even opposite, functions in response to changing tissue contexts. Human cardiac mast cells display significant differences compared with mast cells isolated from other organs. These characteristics make cardiac mast cells intriguing, given their dichotomous potential roles of inducing or protecting against cardiovascular diseases. Identification of cardiac mast cell subpopulations represents a prerequisite for understanding their potential multifaceted roles in health and disease. Several new drugs specifically targeting human mast cell activation are under development or in clinical trials. Mast cells and/or their subpopulations can potentially represent novel therapeutic targets for cardiovascular disorders.

Indexed as

Cardiovascular DiseasesMast CellsAnimalsCardiovascular AgentsCell PlasticityHumansInflammation MediatorsMyocardiumPhenotypeSignal TransductionCardiovascular AgentsInflammation MediatorsAllergyAtherosclerosisCardiovascular diseasesHeart failureMast cellsMyocardial infarctionMyocarditis

Identifiers

PMID38630620
PMCPMC11135650
OpenAlexW4394892745

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.